LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
German Center for Neurodegenerative Diseases (Dzne)
Headquarters:
Bonn, Germany
Website:
https://www.dzne.de/en
Year Founded:
2009
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Nov 10, 2023
Discovery & Translation
Shinobi’s immune-protected cell therapies; plus Emugen, AZ and more
BioCentury’s roundup of translational innovations
Read More
BioCentury
|
Nov 6, 2020
Targets & Mechanisms
Data Byte: newly identified host factors that regulate ACE2 expression
Several recent publications highlighting host factors that modulate ACE2 expression point to possible new targets for COVID-19 therapies. ACE2 and TMPRSS2 are the most common host targets
Read More
BioCentury
|
Aug 29, 2019
Preclinical News
Aug. 29 Preclinical Quick Takes: New targets for leukemia from Calico and stroke from Gero; predictors of checkpoint inhibitor response and more
Read More
BioCentury
|
May 28, 2019
Distillery Therapeutics
TSPO agonist to treat Parkinson's disease
Read More
BioCentury
|
Jan 30, 2019
Distillery Techniques
Biomarkers
Read More
BioCentury
|
Jan 23, 2019
Preclinical News
Neurofilament light chain could predict familial Alzheimer's progression
Read More
BioCentury
|
Jun 13, 2018
Distillery Therapeutics
Neurology
Read More
Items per page:
10
1 - 7 of 7
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help